| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A Checklist for Medication Compliance and Persistence Studies Using Retrospective Databases
|
Peterson, Andrew M.
|
|
2007
|
10 |
1 |
p. 3-12
10 p.
|
artikel
|
| 2 |
A Checklist for Medication Compliance and Persistence Studies Using Retrospective Databases
|
Peterson, Andrew M.
|
|
2007
|
10 |
1 |
p. 3-12
|
artikel
|
| 3 |
Cardioverter Defibrillators in Primary Prevention of Sudden Cardiac Death: A Cost or an Investment?
|
Boriani, Giuseppe
|
|
2007
|
10 |
1 |
p. 1-2
2 p.
|
artikel
|
| 4 |
Cardioverter Defibrillators in Primary Prevention of Sudden Cardiac Death: A Cost or an Investment?
|
Boriani, Giuseppe
|
|
2007
|
10 |
1 |
p. 1-2
|
artikel
|
| 5 |
Cost-Benefit Analysis of Preventing Sudden Cardiac Deaths with an Implantable Cardioverter Defibrillator versus Amiodarone
|
Caro, J. Jaime
|
|
2007
|
10 |
1 |
p. 13-22
10 p.
|
artikel
|
| 6 |
Cost-Benefit Analysis of Preventing Sudden Cardiac Deaths with an Implantable Cardioverter Defibrillator versus Amiodarone
|
Caro, J. Jaime
|
|
2007
|
10 |
1 |
p. 13-22
|
artikel
|
| 7 |
Cost-Effectiveness Analysis of a Quality-Controlled Mammography Screening Program from the Swiss Statutory Health-Care Perspective: Quantitative Assessment of the Most Influential Factors
|
Neeser, Kurt
|
|
2007
|
10 |
1 |
p. 42-53
12 p.
|
artikel
|
| 8 |
Cost-Effectiveness Analysis of a Quality-Controlled Mammography Screening Program from the Swiss Statutory Health-Care Perspective: Quantitative Assessment of the Most Influential Factors
|
Neeser, Kurt
|
|
2007
|
10 |
1 |
p. 42-53
|
artikel
|
| 9 |
Cost-Effectiveness of Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting Associated with Highly Emetogenic Chemotherapy
|
Moore, Susan
|
|
2007
|
10 |
1 |
p. 23-31
9 p.
|
artikel
|
| 10 |
Cost-Effectiveness of Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting Associated with Highly Emetogenic Chemotherapy
|
Moore, Susan
|
|
2007
|
10 |
1 |
p. 23-31
|
artikel
|
| 11 |
Economic Evaluation of Palliative Management versus Peritoneal Dialysis and Hemodialysis for End-Stage Renal Disease: Evidence for Coverage Decisions in Thailand
|
Teerawattananon, Yot
|
|
2007
|
10 |
1 |
p. 61-72
12 p.
|
artikel
|
| 12 |
Economic Evaluation of Palliative Management versus Peritoneal Dialysis and Hemodialysis for End-Stage Renal Disease: Evidence for Coverage Decisions in Thailand
|
Teerawattananon, Yot
|
|
2007
|
10 |
1 |
p. 61-72
|
artikel
|
| 13 |
The Cost-Effectiveness of Lanthanum Carbonate in the Treatment of Hyperphosphatemia in Patients with End-Stage Renal Disease
|
Brennan, Alan
|
|
2007
|
10 |
1 |
p. 32-41
10 p.
|
artikel
|
| 14 |
The Cost-Effectiveness of Lanthanum Carbonate in the Treatment of Hyperphosphatemia in Patients with End-Stage Renal Disease
|
Brennan, Alan
|
|
2007
|
10 |
1 |
p. 32-41
|
artikel
|
| 15 |
The Effect of Disease, Functional Status, and Relapses on the Utility of People with Multiple Sclerosis in the UK
|
Orme, Michelle
|
|
2007
|
10 |
1 |
p. 54-60
7 p.
|
artikel
|
| 16 |
The Effect of Disease, Functional Status, and Relapses on the Utility of People with Multiple Sclerosis in the UK
|
Orme, Michelle
|
|
2007
|
10 |
1 |
p. 54-60
|
artikel
|
| 17 |
Using EQ-5D to Derive General Population-based Utilities for the Quality of Life Assessment of Growth Hormone Deficiency in Adults (QoL-AGHDA)
|
Kołtowska-Häggström, Maria
|
|
2007
|
10 |
1 |
p. 73-81
9 p.
|
artikel
|
| 18 |
Using EQ-5D to Derive General Population-based Utilities for the Quality of Life Assessment of Growth Hormone Deficiency in Adults (QoL-AGHDA)
|
Kołtowska-Häggström, Maria
|
|
2007
|
10 |
1 |
p. 73-81
|
artikel
|
Tijdschrift beschrijving